The Hindu·4 min read·medium
Multi-centric study to contain antimicrobial resistant neonatal sepsis begins in India
R
Ramya Kannan
✦AI Summary
An international clinical trial named NeoSep1 has expanded to India to test new antibiotic combinations for treating neonatal sepsis. The study aims to address the growing threat of antimicrobial resistance in newborns across Asia and Africa.
Striking at the heart of antimicrobial resistance, the international NeoSep 1 trial to evaluate life-saving antibiotic combinations for newborns with sepsis has expanded to India, with the first baby being recruited at the Jawaharlal Postgraduate Education Institute of Medical and Research (JIPMER) in Puducherry.
healthscienceworld
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in